These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 8098275

  • 1. Pharmacokinetics and pharmacodynamics of H2-receptor antagonists in patients with renal insufficiency.
    Gladziwa U, Klotz U.
    Clin Pharmacokinet; 1993 Apr; 24(4):319-32. PubMed ID: 8098275
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
    Lin JH.
    Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nizatidine, and H2-receptor antagonist: disposition and safety in the elderly.
    Callaghan JT, Rubin A, Knadler MP, Bergstrom RF.
    J Clin Pharmacol; 1987 Aug; 27(8):618-24. PubMed ID: 2888796
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers.
    Inotsume N, Nishimura M, Fujiyama S, Sagara K, Sato T, Imai Y, Matsui H, Nakano M.
    Eur J Clin Pharmacol; 1989 Aug; 36(5):517-20. PubMed ID: 2568929
    [Abstract] [Full Text] [Related]

  • 8. Famotidine disposition in children and adolescents with chronic renal insufficiency.
    Maples HD, James LP, Stowe CD, Jones DP, Hak EB, Blumer JL, Vogt B, Wilson JT, Kearns GL, Wells TG, Network of Pediatric Pharmacology Research Units.
    J Clin Pharmacol; 2003 Jan; 43(1):7-14. PubMed ID: 12520622
    [Abstract] [Full Text] [Related]

  • 9. A pharmacokinetic profile of nizatidine in man.
    Callaghan JT, Bergstrom RF, Rubin A, Chernish S, Crabtree R, Knadler MP, Obermeyer B, Offen WW, Schneck DW, Aronoff G.
    Scand J Gastroenterol Suppl; 1987 Jan; 136():9-17. PubMed ID: 2892261
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function.
    Takabatake T, Ohta H, Maekawa M, Yamamoto Y, Ishida Y, Hara H, Nakamura S, Ushiogi Y, Kawabata M, Hashimoto N.
    Eur J Clin Pharmacol; 1985 Jan; 28(3):327-31. PubMed ID: 2861096
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Newer H2-receptor antagonists. Clinical pharmacokinetics and drug interaction potential.
    Krishna DR, Klotz U.
    Clin Pharmacokinet; 1988 Oct; 15(4):205-15. PubMed ID: 2903807
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of TZU-0460, a new H2-receptor antagonist, in patients with impaired renal function.
    Takabatake T, Ohta H, Yamamoto Y, Ishida Y, Hara H, Nakamura S, Ushiogi Y, Satoh S, Hattori N.
    Eur J Clin Pharmacol; 1986 Oct; 30(6):709-12. PubMed ID: 2876900
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation.
    Wells TG, Heulitt MJ, Taylor BJ, Fasules JW, Kearns GL.
    J Clin Pharmacol; 1998 May; 38(5):402-7. PubMed ID: 9602950
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of ranitidine and nizatidine in very elderly patients.
    Sasaki M, Sudoh T, Fujimura A.
    Am J Ther; 2005 May; 12(3):223-5. PubMed ID: 15891265
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.